American Shared and USDL end talks

Article

American Shared Hospital Services and U.S. Diagnostic succumbed to the inevitable last month, calling off talks regarding USDL's proposed acquisition of American Shared. American Shared cited USDL's inability to proceed with the negotiations in a timely

American Shared Hospital Services and U.S. Diagnostic succumbed to the inevitable last month, calling off talks regarding USDL's proposed acquisition of American Shared. American Shared cited USDL's inability to proceed with the negotiations in a timely fashion as the reason for the breakdown.

USDL of West Palm Beach, FL, and San Francisco-based American Shared first announced the proposed deal Dec. 11 (SCAN 12/18/96). USDL agreed to buy American Shared for $2.25 a share, payable in USDL stock, which was trading at around $12 a share when the deal was announced. USDL later increased the bid to $2.40 a share.

Two weeks later, however, revelations surfaced about the criminal record of USDL mergers and acquisitions consultant Keith Greenberg of Coyote Consulting. USDL's stock subsequently tanked, falling as low as $5.38. It has since rebounded, trading at around $8.75 last week. But that's still not high enough to make the deal attractive to USDL, according to CEO Joseph Paul.

American Shared will continue to entertain "expressions of interest" in the company, according to chairman and CEO Dr. Ernest Bates. The company will also pursue growth in its core business, as well as potential acquisitions, he said.

In addition to the USDL news, American Shared posted first-quarter financial results that indicated revenues of $9.1 million, up 2% compared with sales of $8.9 million in the first quarter of 1996. The company had net income of $39,000, compared with a net loss of $480,000.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.